Palo Alto Health Sciences

Palo Alto Health Sciences is a privately held Kirkland WA-based digital therapeutics company founded in 2013.  The flagship product, Freespira, is an FDA-cleared, evidence-based treatment indicated for patients diagnosed with panic attacks, panic disorder and PTSD.  Freespira corrects the abnormal respiratory patterns associated with these conditions by training the patient to normalize their breathing rate and exhaled CO2 levels. Freespira is medication-free, takes only one month to complete, and is used at home. Results are long lasting, and treatment is authorized by a licensed healthcare provider and can be delivered by a behavioral health clinician or a Freespira coach.

 

Recent research publication/features links: